0000000000413367

AUTHOR

Marc Ehlers

0000-0002-5383-8603

showing 6 related works from this author

Yeast expression of the cytokine receptor domain of the soluble interleukin-6 receptor

1996

Abstract The complex of the soluble interleukin-6 receptor (sIL-6R) and IL-6 (IL-6) is a potent agonist on cells expressing the signal transducing protein gp130. In contrast, IL-6 alone only stimulates cells which express a membrane bound form of the IL-6R and gp130. The natural occurring sIL-6R is generated by shedding of the membrane receptor and to a lesser extend by alternative splicing. We have inserted the coding sequence of the 323 amino acid residues of the human sIL-6R into an expression/secretion vector suitable for the methylotrophic yeast Pichia pastoris . We obtained, however, no detectable expression and secretion of the recombinant protein. When we used only the coding sequen…

Protein ConformationGenetic VectorsImmunologyReceptors InterleukinInterleukin-17 receptorBiologyGlycoprotein 130biology.organism_classificationReceptors Interleukin-6Molecular biologyPichiaPichia pastorisSolubilityAntigens CDInterleukin-4 receptorInterleukin-21 receptorImmunology and Allergy5-HT5A receptorReceptors CytokineCytokine receptorCommon gamma chainJournal of Immunological Methods
researchProduct

The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prol…

1996

Interleukin 6 (IL-6) is considered an important mediator of acute inflammatory responses. Moreover, IL-6 functions as a differentiation and growth factor of hematopoietic precursor cells, B cells, T cells, keratinocytes, neuronal cells, osteoclasts, and endothelial cells. IL-6 exhibits its action via a receptor complex consisting of a specific IL-6 receptor (IL-6R) and a signal transducing subunit (gp130). Soluble forms of both receptor components are generated by shedding and are found in patients with various diseases such as acquired immune deficiency syndrome, rheumatoid arthritis, and others. The function of the soluble (s)IL-6R in vivo is unknown. Since human (h)IL-6 acts on human and…

Receptor complexImmunologyMice TransgenicInterleukin 1 receptor type IIBiologyMiceSpecies SpecificityAntigens CDInterleukin-4 receptorImmunology and AllergyAnimalsHumansAcute-Phase ReactionInterleukin 12 receptor beta 1 subunitInterleukin 3HaptoglobinsInterleukin-6Receptors InterleukinArticlesMolecular biologyReceptors Interleukin-6Interleukin 10LiverSolubilityInterleukin-6 receptorPhosphoenolpyruvate Carboxykinase (GTP)Interleukin 1 receptor type ICarrier ProteinsHalf-LifeThe Journal of experimental medicine
researchProduct

IgG Fc sialylation is regulated during the germinal center reaction following immunization with different adjuvants

2020

Background: Effector functions of IgG Abs are regulated by their Fc N-glycosylation pattern. IgG Fc glycans that lack galactose and terminal sialic acid residues correlate with the severity of inflammatory (auto)immune disorders and have also been linked to protection against viral infection and discussed in the context of vaccine-induced protection. In contrast, sialylated IgG Abs have shown immunosuppressive effects.Objective: We sought to investigate IgG glycosylation programming during the germinal center (GC) reaction following immunization of mice with a foreign protein antigen and different adjuvants.Methods: Mice were analyzed for GC T-cell, B-cell, and plasma cell responses, as wel…

Lipopolysaccharides0301 basic medicineGlycosylationT-LymphocytesFreund's AdjuvantPolysorbatesPlasma cellchemistry.chemical_compound0302 clinical medicineImmunology and AllergyMice KnockoutB-Lymphocytesbiologyddc:3. Good healthT follicular cellsIL-17medicine.anatomical_structureAlum CompoundsCytokinesFemaleAntibodySqualeneGlycosylationOvalbuminIgG glycosylationImmunologyAntibodiesIFN-gamma03 medical and health sciencesImmune systemAdjuvants ImmunologicAntigenmedicineAnimalsMineral OilAntigensIL-6IL-27RCord factorGerminal centerMycobacterium tuberculosisDendritic cellvaccinationMice Inbred C57BLcarbohydrates (lipids)030104 developmental biologychemistryadjuvantsgerminal centerImmunoglobulin GImmunologybiology.protein030215 immunologyJournal of Allergy and Clinical Immunology
researchProduct

Combining two mutations of human interleukin-6 that affect gp130 activation results in a potent interleukin-6 receptor antagonist on human myeloma ce…

1995

The pleiotropic cytokine interleukin-6 (IL-6) interacts with the specific ligand binding subunit (IL-6R alpha) of the IL-6 receptor, and this complex associates with the signal-transducing subunit gp130 (IL-6R beta). Human IL-6 acts on human and murine cells, whereas murine IL-6 is only active on murine cells. The construction of a set of chimeric human/murine IL-6 proteins has recently allowed us to define a region (residues 43-55) within the human IL-6 protein, which is important for the interaction with gp130. Subdividing this region shows that mainly residues 50-55 of the human IL-6 are necessary for this interaction. Recently, another human IL-6 double mutant (Q159E and T162P) showed r…

Protein ConformationProtein subunitmedicine.medical_treatmentMutantMolecular Sequence DataBiologyBiochemistryMiceAntigenAntigens CDmedicineCytokine Receptor gp130Tumor Cells CulturedAnimalsHumansPoint MutationInterleukin 6ReceptorMolecular BiologyMembrane GlycoproteinsBase SequenceInterleukin-6Wild typeCell BiologyReceptors InterleukinGlycoprotein 130Molecular biologyReceptors Interleukin-6CytokineOligodeoxyribonucleotidesbiology.proteinMultiple MyelomaThe Journal of biological chemistry
researchProduct

Identification of Single Amino Acid Residues of Human IL-6 Involved in Receptor Binding and Signal Initiation

1996

The pleiotropic cytokine interleukin-6 (IL-6) has been predicted to be a protein with four antiparallel alpha-helices. On target cells, IL-6 interacts with a specific ligand binding receptor subunit (IL-6R), and this complex associates with the signal-transducing subunit gp130. Human IL-6 acts on human and murine cells, whereas murine IL-6 is only active on murine cells. The construction of chimeric human/murine IL-6 proteins has allowed us to define a region (residues 77-95, region 2c) within the human IL-6 protein that is important for IL-6R binding and a region (residues 50-55, region 2a2) that is important for IL-6R dependent gp130 interaction. Guided by sequence alignment and molecular…

Protein ConformationRecombinant Fusion ProteinsProtein subunitMolecular Sequence DataImmunologySequence alignmentPlasma protein bindingBiologyLigandsMiceStructure-Activity RelationshipProtein structureAntigens CDVirologyCytokine Receptor gp130AnimalsHumansPoint MutationAmino Acid SequenceAmino AcidsReceptorPeptide sequenceMembrane GlycoproteinsInterleukin-6Receptors InterleukinCell BiologyGlycoprotein 130Receptors Interleukin-6BiochemistryMutagenesis Site-DirectedSignal transductionSequence AlignmentProtein BindingSignal TransductionJournal of Interferon & Cytokine Research
researchProduct

The Soluble Interleukin-6 Receptora

2006

biologyChemistryGeneral NeuroscienceLymphokineOncostatin MCiliary neurotrophic factorMolecular biologyGeneral Biochemistry Genetics and Molecular BiologyHistory and Philosophy of Sciencebiology.proteinLeukemia Inhibitory Factor Receptor alpha SubunitInterleukin 6ReceptorPeptide sequenceLeukemia inhibitory factorAnnals of the New York Academy of Sciences
researchProduct